SoftWave Vitality

SoftWave Vitality opened in April 2025 and is dedicated entirely to SoftWave, which is the only treatment offered. The practice works with shockwave (acoustic wave) therapy, which the business describes as stimulating the body's natural healing response and improving blood flow. Its listed focus areas are chronic lower back pain and muscular tension, rotator cuff tendinopathy and frozen shoulder, knee arthritis and overuse injuries, outer hip pain from gluteal tendinopathy or hip bursitis, and sports-related pain in the elbow, wrist, hip and other soft-tissue areas.

Founder Bill Weatherford leads the practice. A new client's first visit costs $59 and includes a consultation, a mapping session and a first SoftWave treatment, so people can try the therapy before deciding whether to continue. The business describes that package as a $300 value. Medical history is reviewed at the first visit to determine eligibility. During the mapping session the device moves across the general area of concern to find where treatment should focus, and clients can feel the sensation in real time before agreeing to a plan. Treatment is usually described as a light tapping or pulsing feeling, and the provider can adjust intensity. Most clients are described as returning to normal activity the same day.

The business says most conditions need a series of 4 to 8 treatments for best results, according to its FAQ. Side effects are described as rare, with temporary redness or soreness that usually settles within 24 to 48 hours. Treatment is not recommended for pregnant people, people with a pacemaker, or people with active cancer near the treatment site. The FAQ says it can be used alongside most prescription medications and after surgery or with metal implants.

Most insurance plans do not cover SoftWave, though it may qualify for HSA or FSA reimbursement. Gift cards for SoftWave Therapy are available. The business displays a Google rating of 5.0 from 93 reviews and a Yelp rating of 5.00 from 51 reviews.

Regulatory status differs by use. The FDA has cleared the device for three purposes: stimulating connective tissue, briefly boosting blood flow in a targeted area, and easing minor muscle soreness. Certain other conditions, such as plantar fasciitis and some tendon disorders, are covered by Health Canada licensing instead of any FDA-cleared indication. Independent studies of shockwave therapy have found pain or functional gains in some participant groups, though outcomes depend on the specific condition and the treatment protocol used.

Non-invasive and science-based, with a human-centered focus: no needles or medication are used, and a mapping session comes before any treatment plan is set.